Showing results (1-10 of 80) with videos related to
Sort By:
Pageof 8
Cancer|October 24, 2022
Immune check point inhibitors in advanced cutaneous squamous cell carcinomas: "Repeat and replicate"Conor E Steuer, Nabil F SabaCurrent Treatment Options in Oncology|March 4, 2022
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?James E Bates, Conor E SteuerJCO Oncology Practice|June 25, 2021
Advances in Immunotherapy and Implications for Current Practice in Non-Small-Cell Lung CancerConor E Steuer, Suresh S RamalingamCancer|May 24, 2014
ALK-positive non-small cell lung cancer: mechanisms of resistance and emerging treatment optionsConor E Steuer, Suresh S RamalingamMolecular Aspects of Medicine|May 30, 2015
Targeting EGFR in lung cancer: Lessons learned and future perspectivesConor E Steuer, Suresh S RamalingamAnnual Review of Medicine|September 14, 2016
The End of Nihilism: Systemic Therapy of Advanced Non-Small Cell Lung CancerVinicius Ernani, Conor E Steuer, Mohammad JahanzebCancer|December 19, 2014
The next generation of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of lung cancerConor E Steuer, Fadlo R Khuri, Suresh S RamalingamCA: a Cancer Journal for Clinicians|August 26, 2020
An update on the immune landscape in lung and head and neck cancersJennifer W Carlisle, Conor E Steuer, Taofeek K Owonikoko, et al.CA: a Cancer Journal for Clinicians|November 30, 2016
An update on larynx cancerConor E Steuer, Mark El-Deiry, Jason R Parks, et al.Translational Cancer Research|February 12, 2026
Survival and response outcomes in patients with recurrent/metastatic head and neck cancer treated with opioids and statins: an exploratory pilot studyElihu Igbinadolor, Tyler J Kristoff, Dong M Shin, et al.Pageof 8